PurposeQuality assurance (QA) of magnetic resonance imaging (MRI) for gel dosimetry using an in-house phantom was established to ensure consistent dosimetric performance. MethodsA normoxic N-vinylpyrrolidone-based gel dosimeter sensitized with an inorganic salt was used. Each individual gel dosimeter, in addition to a specially designed image QA phantom, was imaged at three institutions with different MRI systems. ResultsBoth the gel dosimeter and QA phantom had linear dose–response curves at all institutions, with correlation coefficients = 1.00 and ≥ 0.99, respectively. Minor inter-institutional variations in the sensitivity (gel dosimeter, 0.096 ± 0.010 s−1Gy−1; QA phantom, 0.140 ± 0.003 s−1Gy−1) and offset value (gel dosimeter, 2.188 ± 0.222 s−1; QA phantom, 3.318 ± 0.081 s−1) were found. Dose uncertainties for the gel dosimeter ranged from 3.2% to 3.5% at 10 Gy and 1.7%–2.1% at 20 Gy, and these were comparable with the corresponding QA phantom uncertainties. Dose resolutions were 0.8–1.2 Gy for the gel dosimeter and 0.6–1.4 Gy for the QA phantom. Uniformity factors were ≥98% at all institutions. Spatial linearity had a geometric distortion ≤1.0%, Gamma passing rates of 95%–100% met recommended QA guidelines; strong correlations between the QA phantom and gel dosimeter were also obtained for each of these measures. ConclusionOur study demonstrates the viability of applying MRI acquisition parameters validated using a QA phantom to polymer gel dosimetry across diverse MRI systems. This approach enables robust QA measures, focusing on effective management of uniformity and dose uncertainty.
Read full abstract